© 2026 New England Public Media

FCC public inspection files:
WGBY • WFCR • WNNZ • WNNU • WNNZ-FM • WNNI

For assistance accessing our public files, please contact hello@nepm.org or call 413-781-2801.
PBS, NPR and local perspective for western Mass.
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

New mRNA vaccine could reduce the recurrence and spread of skin cancer

NPR | By Leila Fadel
Published August 20, 2026 at 4:45 AM EDT

Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.

Copyright 2026 NPR
Leila Fadel
Leila Fadel is a host of Morning Edition, as well as NPR's morning news podcast Up First.
See stories by Leila Fadel